• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估血糖结果中的隐藏复杂性:质量排名与治疗是否一致?

Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment?

机构信息

Department of Veterans Affairs New Jersey Healthcare System, East Orange, New Jersey, USA.

出版信息

Diabetes Care. 2010 Oct;33(10):2133-9. doi: 10.2337/dc09-1665. Epub 2010 Jul 9.

DOI:10.2337/dc09-1665
PMID:20622158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2945148/
Abstract

OBJECTIVE

To evaluate facility rankings in achieving <7% A1C levels based on the complexity of glycemic treatment regimens using threshold and continuous measures.

RESEARCH DESIGN AND METHODS

We conducted a retrospective administrative data analysis of Veterans Health Administration Medical Centers in 2003-2004. Eligible patients were identified using National Committee for Quality Assurance (NCQA) measure specifications. A complex glycemic regimen (CGR) was defined as receipt of insulin or three oral agents. Facilities were ranked using five ordinal categories based up both z score distribution and statistical significance (P < 0.05). Rankings using the NCQA definition were compared with a subset receiving CGRs using both a <7% threshold and a continuous measure awarding proportional credit for values between 7.9 and <7.0%. Ranking correlation was assessed using the Spearman correlation coefficient.

RESULTS

A total of 203,302 patients (mean age 55.2 years) were identified from 127 facilities (range 480-5,411, mean 1,601); 26.7% (17.9-35.2%) were receiving CGRs, including 22.0% receiving insulin. Mean A1C and percent achieving A1C <7% were 7.48 and 48% overall and 8.32 and 24.8% for those receiving CGRs using the threshold measure; proportion achieved was 60.1 and 37.2%, respectively, using the continuous measure. Rank correlation between the overall and CGR subset was 0.61; 8 of 24 of the highest or lowest ranked facilities changed to nonsignificance status; an additional five sites changed rankings.

CONCLUSIONS

Facility rankings in achieving the NCQA <7% measure as specified differ markedly from rankings using the CGR subset. Measurement for public reporting or payment should stratify rankings by CGR. A continuous measure may better align incentives with treatment intensity.

摘要

目的

使用阈值和连续测量方法,根据血糖治疗方案的复杂性评估设施在达到 <7% A1C 水平方面的排名。

研究设计和方法

我们对 2003-2004 年退伍军人健康管理局医疗中心进行了回顾性行政数据分析。使用国家质量保证委员会 (NCQA) 测量规范确定合格患者。复杂血糖方案 (CGR) 的定义是接受胰岛素或三种口服药物。根据 z 分数分布和统计学意义 (P < 0.05),使用五个有序类别对设施进行排名。使用 NCQA 定义的排名与使用 <7% 阈值和连续测量方法为 7.9 至 <7.0% 之间的值授予比例信用的 CGR 子集进行比较。使用 Spearman 相关系数评估排名相关性。

结果

从 127 家医疗机构(范围 480-5411,平均 1601)中确定了 203302 名患者(平均年龄 55.2 岁);26.7%(17.9-35.2%)接受 CGR,包括 22.0%接受胰岛素。总体而言,A1C 的平均值和达到 A1C <7%的百分比分别为 7.48%和 48%,对于使用阈值测量的接受 CGR 的患者分别为 8.32%和 24.8%;使用连续测量,分别为 60.1%和 37.2%。整体和 CGR 子集之间的排名相关性为 0.61;24 家排名最高或最低的医疗机构中有 8 家变为无统计学意义;另外五家机构的排名发生了变化。

结论

根据 NCQA 规定的 <7% 测量值,医疗机构的排名与使用 CGR 子集的排名有很大差异。为了进行公共报告或支付,测量方法应按 CGR 对排名进行分层。连续测量可能会使激励措施与治疗强度更好地保持一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7030/2945148/dc32526a178c/zdc0101084940001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7030/2945148/dc32526a178c/zdc0101084940001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7030/2945148/dc32526a178c/zdc0101084940001.jpg

相似文献

1
Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment?评估血糖结果中的隐藏复杂性:质量排名与治疗是否一致?
Diabetes Care. 2010 Oct;33(10):2133-9. doi: 10.2337/dc09-1665. Epub 2010 Jul 9.
2
Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?在评估医疗保健计划在实现最佳血糖控制方面的表现时,是否应考虑减轻合并症?
Am J Manag Care. 2007 Mar;13(3):133-40.
3
Comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration.退伍军人健康管理局中血糖控制的加权绩效测量与二分阈值比较。
Diabetes Care. 2006 Feb;29(2):241-6. doi: 10.2337/diacare.29.02.06.dc05-1468.
4
A Proposal for an Out-of-Range Glycemic Population Health Safety Measure for Older Adults With Diabetes.一项针对老年糖尿病患者血糖超出范围的人群健康安全措施的提议。
Diabetes Care. 2017 Apr;40(4):518-525. doi: 10.2337/dc16-0953. Epub 2016 Nov 15.
5
Assessing potential glycemic overtreatment in persons at hypoglycemic risk.评估低血糖风险人群中潜在的过度血糖治疗。
JAMA Intern Med. 2014 Feb 1;174(2):259-68. doi: 10.1001/jamainternmed.2013.12963.
6
Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.2型糖尿病患者起始胰岛素治疗:疗效、并发症及资源利用情况
JAMA. 1997 Nov 26;278(20):1663-9.
7
Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus.2型糖尿病初级护理患者的血糖控制及糖化血红蛋白的应用
Prim Care Diabetes. 2015 Oct;9(5):385-91. doi: 10.1016/j.pcd.2015.01.006. Epub 2015 Feb 14.
8
Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes.新发 2 型糖尿病患者起始胰岛素治疗后的血糖反应和糖化血红蛋白达标情况。
Diabetes Care. 2012 Mar;35(3):495-7. doi: 10.2337/dc11-1171. Epub 2012 Jan 25.
9
Refill adherence to oral hypoglycemic agents and glycemic control in veterans.退伍军人中口服降糖药的续用率和血糖控制情况。
Ann Pharmacother. 2010 May;44(5):800-8. doi: 10.1345/aph.1M570. Epub 2010 Apr 13.
10
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.基础胰岛素主动滴定与常规算法滴定以及即时检测糖化血红蛋白(HbA1c)与实验室检测对2型糖尿病患者血糖控制的影响:即时检测算法与实验室糖化血红蛋白血糖优化(GOAL A1C)试验
Diabetes Care. 2006 Jan;29(1):1-8. doi: 10.2337/diacare.29.01.06.dc05-1058.

引用本文的文献

1
Corporate Logic in Clinical Care: The Case of Diabetes Management.企业逻辑在临床护理中的体现:以糖尿病管理为例。
Med Anthropol Q. 2019 Dec;33(4):463-482. doi: 10.1111/maq.12533. Epub 2019 Nov 19.
2
The role of matching when adjusting for baseline differences in the outcome variable of comparative effectiveness studies.在比较效果研究的结果变量中对基线差异进行调整时匹配的作用。
J Comp Eff Res. 2015 Aug;4(4):341-9. doi: 10.2217/cer.15.16.
3
Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.

本文引用的文献

1
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.2 型糖尿病患者症状性、严重低血糖与死亡的相关性:ACCORD 研究的回顾性流行病学分析。
BMJ. 2010 Jan 8;340:b4909. doi: 10.1136/bmj.b4909.
2
Mitigating case mix factors by choice of glycemic control performance measure threshold.通过选择血糖控制绩效指标阈值来减轻病例组合因素的影响。
Diabetes Care. 2008 Sep;31(9):1754-60. doi: 10.2337/dc07-2010. Epub 2008 May 28.
3
Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern?
糖尿病绩效薪酬激励设计变化对患者风险选择的影响。
Health Serv Res. 2016 Apr;51(2):667-86. doi: 10.1111/1475-6773.12338. Epub 2015 Jul 7.
4
Quality indicators and performance measures in diabetes care.糖尿病护理中的质量指标和绩效衡量标准。
Curr Diab Rep. 2014 Mar;14(3):472. doi: 10.1007/s11892-013-0472-y.
5
The changing face of chronic illness management in primary care: a qualitative study of underlying influences and unintended outcomes.基层医疗中慢性病管理模式的变化:一项对潜在影响和意外结果的定性研究。
Ann Fam Med. 2012 Sep-Oct;10(5):452-60. doi: 10.1370/afm.1380.
6
Clinical complexity and mortality in middle-aged and older adults with diabetes.中年和老年糖尿病患者的临床复杂性和死亡率。
J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1313-20. doi: 10.1093/gerona/gls095. Epub 2012 Apr 6.
糖化血红蛋白检测的认证方法中的分析偏差:值得关注的一个原因?
Am J Clin Pathol. 2008 Apr;129(4):540-7. doi: 10.1309/U3GPPTCBP1VLL8AW.
4
One size does not fit all: the need for a continuous measure for glycemic control in diabetes.
Jt Comm J Qual Patient Saf. 2007 Oct;33(10):636-43. doi: 10.1016/s1553-7250(07)33073-0.
5
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.2型糖尿病患者在口服治疗基础上加用双相、餐时或基础胰岛素。
N Engl J Med. 2007 Oct 25;357(17):1716-30. doi: 10.1056/NEJMoa075392. Epub 2007 Sep 21.
6
Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians.血糖控制与2型糖尿病:最佳糖化血红蛋白目标。美国医师学会的一份指导声明。
Ann Intern Med. 2007 Sep 18;147(6):417-22. doi: 10.7326/0003-4819-147-6-200709180-00012.
7
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.长效胰岛素类似物与NPH胰岛素(人低精蛋白胰岛素)治疗2型糖尿病的比较
Cochrane Database Syst Rev. 2007 Apr 18(2):CD005613. doi: 10.1002/14651858.CD005613.pub3.
8
Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?在评估医疗保健计划在实现最佳血糖控制方面的表现时,是否应考虑减轻合并症?
Am J Manag Care. 2007 Mar;13(3):133-40.
9
Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration.退伍军人健康管理局中自我报告的患者特征对血糖控制评估的影响。
Diabetes Care. 2007 Feb;30(2):245-51. doi: 10.2337/dc06-0771.
10
Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration.推进糖尿病的循证护理:退伍军人健康管理局的经验教训。
Health Aff (Millwood). 2007 Mar-Apr;26(2):w156-68. doi: 10.1377/hlthaff.26.2.w156. Epub 2007 Jan 26.